HOPA is committed providing high quality education that is strongly integrated with HOPA’s core passion to support pharmacy practitioners and promote and advance Hematology/Oncology Pharmacy to optimize the care of individuals affected by cancer. HOPA strives to become the destination of choice for quality education focused on creating competent hematology/oncology pharmacists with sound domain knowledge, skills and managerial acumen.  Below is the full spectrum of education offerings – you may also sort by content area, date, delivery method, and if it offers BCOP recertification credit.

John G. Kuhn Keynote Lecture-"There will be drugs": Lessons from Lung Cancer’s Therapeutic Oil Boom

Originally presented at HOPA's 14th Annual Conference, March 2018.

In the last 10 years two revolutions have occurred in the treatment of lung cancer, particularly non-small-cell lung cancer: the personalized medicine revolution and the immunotherapy revolution. Each has led to a boom in U.S. Food and Drug Administration drug approvals and National Comprehensive Cancer Network recommendations. But with each development have come lessons to be learned about side effects, acquired resistance, drug interactions, gaps in our clinical development strategies, and how these two revolutions overlap.

As we keep patients with advanced lung cancer alive longer, we are turning the condition into a chronic disease, with the need to manage multiple co-occurring independent and dependent disease-related and iatrogenic conditions at the same time. In addition, we now have to take on some of the challenges of maintaining normality in someone who wants to continue living life to the fullest despite having advanced cancer. The teamwork of pharmacists and medical oncologists in research and standard of care has never been more important.


Ross Camidge, MD PhD

Activity type

Advocay & Public Policy

Accreditation Statement

logo acpe

The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by March 22, 2021.

This activity has been approved for .1 CEU

This course is also included as part of the Best of 2018 Annual Conference Recordings Bundle.

Release Date: September 26, 2018

Expiration Date: March 22, 2021

Member: $25

Non-Member: $35

Purchase Now